Literature DB >> 17334799

Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo.

Giuliano Pillolla1, Miriam Melis, Simona Perra, Anna Lisa Muntoni, Gian Luigi Gessa, Marco Pistis.   

Abstract

RATIONALE: Endocannabinoid-mediated forms of transient synaptic depression have been described in several brain structures, including the dopaminergic ventral tegmental area (VTA). However, their functional and/or behavioural correlates are yet to be determined.
OBJECTIVES: The present study was designed to investigate whether back-propagating action potentials in dopamine (DA) neurons, evoked by the stimulation of the medial forebrain bundle (MFB), could trigger endocannabinoid-mediated forms of synaptic modulation. The MFB contains axons ascending from DA neurons to the nucleus accumbens and other forebrain structures, and its stimulation is rewarding because it elicits intra-cranial self-stimulation.
MATERIALS AND METHODS: Single cell extracellular recordings were carried out from anti-dromically identified VTA DA neurons in chloral hydrate anesthetized rats.
RESULTS: DA neurons responded to MFB stimulation (1 s, 20-80 Hz) with a frequency-dependent increase in spontaneous firing rate, which was enhanced by the cannabinoid type-1 receptor antagonist SR141716A (1 mg/kg) and depressed by the agonist WIN55212-2 (0.125 mg/kg). Increasing brain levels of the endocannabinoid anandamide by blocking its major hydrolysing enzyme, fatty-acid amide hydrolase, with URB597 (0.1 mg/kg) was ineffective, whereas blockade of the endocannabinoid membrane transporter with UCM707 (1 mg/kg) enhanced post-stimulus firing rate.
CONCLUSIONS: Our study indicates that stimulation of the MFB evokes an endocannabinoid-mediated short-term modulation of DA neuron activity. Thus, endocannabinoids might play an important role in the mechanisms underlying the rewarding properties of MFB stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334799     DOI: 10.1007/s00213-007-0733-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

1.  Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.

Authors:  Eva de Lago; Stefania Petrosino; Marta Valenti; Enrico Morera; Silvia Ortega-Gutierrez; Javier Fernandez-Ruiz; Vincenzo Di Marzo
Journal:  Biochem Pharmacol       Date:  2005-08-01       Impact factor: 5.858

Review 2.  Involvement of the endocannabinoid system in drug addiction.

Authors:  Rafael Maldonado; Olga Valverde; Fernando Berrendero
Journal:  Trends Neurosci       Date:  2006-02-17       Impact factor: 13.837

3.  Evidence implicating descending fibers in self-stimulation of the medial forebrain bundle.

Authors:  C Bielajew; P Shizgal
Journal:  J Neurosci       Date:  1986-04       Impact factor: 6.167

4.  Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.

Authors:  Z B You; Y Q Chen; R A Wise
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  A portrait of the substrate for self-stimulation.

Authors:  C R Gallistel; P Shizgal; J S Yeomans
Journal:  Psychol Rev       Date:  1981-05       Impact factor: 8.934

Review 6.  Pharmacological actions of cannabinoids.

Authors:  R G Pertwee
Journal:  Handb Exp Pharmacol       Date:  2005

7.  Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

Authors:  Miriam Melis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Beat Lutz; Giovanni Marsicano; Vincenzo Di Marzo; Gian Luigi Gessa; Marco Pistis
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

Review 8.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

Authors:  M Lepore; X Liu; V Savage; D Matalon; E L Gardner
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

10.  Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide.

Authors:  N Ueda; Y Kurahashi; S Yamamoto; T Tokunaga
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

View more
  13 in total

Review 1.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

2.  Using dopamine research to generate rational cannabinoid drug policy.

Authors:  G C Loewinger; E B Oleson; J F Cheer
Journal:  Drug Test Anal       Date:  2012-09-19       Impact factor: 3.345

3.  Bi-directional modulation of food habit expression by the endocannabinoid system.

Authors:  Carol A Gianessi; Stephanie M Groman; Jane R Taylor
Journal:  Eur J Neurosci       Date:  2019-01-11       Impact factor: 3.386

4.  Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.

Authors:  Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

Review 5.  The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives.

Authors:  Theodore Garland; Heidi Schutz; Mark A Chappell; Brooke K Keeney; Thomas H Meek; Lynn E Copes; Wendy Acosta; Clemens Drenowatz; Robert C Maciel; Gertjan van Dijk; Catherine M Kotz; Joey C Eisenmann
Journal:  J Exp Biol       Date:  2011-01-15       Impact factor: 3.312

6.  The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.

Authors:  Maria Scherma; Zuzana Justinová; Claudio Zanettini; Leigh V Panlilio; Paola Mascia; Paola Fadda; Walter Fratta; Alexandros Makriyannis; Subramanian K Vadivel; Islam Gamaleddin; Bernard Le Foll; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.

Authors:  Lauren M Reynolds; Elif Engin; Gabriella Tantillo; Hew Mun Lau; John W Muschamp; William A Carlezon; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

Review 8.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

9.  Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.

Authors:  Louise Adermark; David M Lovinger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

Review 10.  Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.

Authors:  Miriam Melis; Marco Pistis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.